The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

(2020) Jasper Fuk-Woo Chan et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus

(2020) Tiantian Li et al.   Frontiers in Pharmacology

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

(2020) Xiaobo Yang et al.   Lancet Respiratory Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

(2020) Wen Zhang et al.   CLINICAL IMMUNOLOGY

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

(2020) Chi Zhang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Coronavirus Disease 2019 (COVID‐19): What we know?

(2020) Feng He et al.   JOURNAL OF MEDICAL VIROLOGY

New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws

(2020) Francesco Bennardo et al.   ORAL ONCOLOGY

Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine

(2020) Ruijin Qiu et al.   Frontiers in Pharmacology

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Bo Diao et al.   Frontiers in Immunology

Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19

(2020) Li Ni et al.   Frontiers of Medicine

The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response

(2020) Fernanda I Arnaldez et al.   Journal for ImmunoTherapy of Cancer

Clinical features of severe patients infected with 2019 novel coronavirus: a systematic review and meta-analysis

(2020) Daozheng Huang et al.   Annals of Translational Medicine

Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study

(2020) Yue-Ping Liu et al.   Annals of Translational Medicine

Potential effectiveness and safety of antiviral agents in children with coronavirus disease 2019: a rapid review and meta-analysis

(2020) Qianling Shi et al.   Annals of Translational Medicine

Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus

(2020) Yulong Zhou et al.   Annals of Palliative Medicine

Pharmaco-Immunomodulatory Therapy in COVID-19

(2020) John G. Rizk et al.   DRUGS

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

(2020) Qing Ye et al.   JOURNAL OF INFECTION

Prediction of the Severity of the Coronavirus Disease and Its Adverse Clinical Outcomes

(2020) Xiaohui Liu et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia

(2019) Yuanlin Song et al.   CRITICAL CARE MEDICINE

Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): protocol for a randomised controlled trial

(2019) Songqiao Liu et al.   BMJ Open

The preventive effect of Chinese herbal preparation Xuebijing against hyperactive inflammation after hepato-pancreato-biliary surgery

(2019) Qifan Zhang et al.   Annals of Translational Medicine

Severe Acute Respiratory Syndrome

(2019) David S.C. Hui et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

(2017) Rudragouda Channappanavar et al.   Seminars in Immunopathology

Immunotherapeutic implications of IL-6 blockade for cytokine storm

(2016) Toshio Tanaka et al.   Immunotherapy

Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial

(2016) Ping Wang et al.   Trials

Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation

(2014) Qin Yin et al.   Evidence-based Complementary and Alternative Medicine

Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis

(2014) MING-WEI LIU et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Into the Eye of the Cytokine Storm

(2012) J. R. Tisoncik et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia

(2009) G. Hillas et al.   EUROPEAN RESPIRATORY JOURNAL